C-Suite Transitions – CEO Transitions at Netflix

Welcome to edition 25 of C-Suite Transitions, a weekly series on InsideArbitrage that tracks appointments and departures at publicly traded companies during the prior week. We highlight five appointments and departures each week by picking the largest companies from the full list of management changes.

1. NeuroBo Pharmaceuticals (NRBO): On January 12, 2023, Gil Price, M.D. resigned as Chief Executive Officer and President, effective immediately.
2. NetFlix (NFLX): On January 13, 2023, Reed Hastings stepped down as CO-CEO of the company, effective immediately.
3. Catalyst Biosciences (CBIO): On January 15, 2023, Catalyst Biosciences terminated Grant Blouse Ph.D. from his position as the Chief Scientific Officer, effective as of January 15, 2023.

Founded in 1997 by Reed Hastings and Marc Randolph, Netflix with more than 223 million paid subscribers in over 190 countries, is the most popular streaming entertainment service in the world.

On January 20, 2023, Netflix announced that Reed Hastings has resigned from his role as co-Chief Executive Officer and President of the company, but remains an employee of the company in his new role as Executive Chairman, effective January 13, 2023. Chief Operating Officer Greg Peters, will now work with Ted Sarandos, who has been  co-CEO since 2020.

Reed Hastings, Netflix co-Founder and Former CEO

Known for his innovative leadership approach, Netflix co-founder Reed Hastings is stepping down from his position as CEO after 25 years.

Only plus or premium subscribers can access this post. Subscribe today.